London-headquartered biotech startup Verdiva has emerged from stealth with a whopping $410mn for a new range of drugs aimed at tackling the obesity epidemic. It’s one of Europe’s largest-ever biot [...]
Novo Nordisk (NVO) makes Ozempic, the best-known GLP-1 drug out today. And until quite recently, the Danish pharma giant consistently led the pack in new prescriptions, becoming virtually synonymous w [...]
One malicious prompt gets blocked, while ten prompts get through. That gap defines the difference between passing benchmarks and withstanding real-world attacks — and it's a gap most enterprise [...]
Novo Nordisk just cut the price of its weight-loss drug, Wegovy, by more than half for patients who pay without insurance. Amgen (AMGN) announced this week that it has begun two late-stage clinical tr [...]
Run a prompt injection attack against Claude Opus 4.6 in a constrained coding environment, and it fails every time, 0% success rate across 200 attempts, no safeguards needed. Move that same attack to [...]